DINABIOS
LIVE

Serial Number

79393117

Owner

DiNABIOS AG

Attorney

Alexander Montgomery

Filing Date

Jan 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DINABIOS Trademark

Serial Number: 79393117 • Registration: 7805628

DINABIOS is a trademark filed by DiNABIOS AG on January 23, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

DiNABIOS AG (2 trademarks)

Wagistrasse 25

Entity Type: 25

Trademark Details

Filing Date

January 23, 2024

Registration Date

May 27, 2025

Published for Opposition

April 8, 2025

Goods & Services

Software development and programming of software and computer software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; computer platform as a service (PAAS) for data processing, storage, and analysis in the fields of medical, biomedical, veterinary and pharmaceutical research and development; stem cell research services; consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research and development services relating to medical, biomedical, veterinary and pharmaceutical preparations; providing information about medical, biomedical, veterinary and pharmaceutical scientific research and development; Biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; scientific research services with respect to the isolation and cultivation of human cells and tissues; programming of computer software for others for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; rental of laboratory apparatus and instruments for scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching purposes for use in medical, biomedical, veterinary and pharmaceutical research and development; rental of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development

Providing medical information with respect to preparing and dispensing medications, in particular for cardiomyopathy, heart failure and kidney diseases; providing medical consultancy and medical information services in the field of medical care as it relates to medical, biomedical, veterinary and pharmaceutical products; genetic screening for medical, biomedical, veterinary and pharmaceutical purposes; human heart and kidney tissue bank services; medical services relating to the removal, treatment and processing of stem cells

Pharmaceutical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; medicinal and biomedical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Biological tissue cultures for medical use; Biological solid organ tissue intended for subsequent implantation; Surgical implants comprising living tissue; grafts, being implants, comprising living heart and kidney tissue; Biochemical preparations for medical use for the treatment of genetic diseases and cancer of solid organs, including heart and muscle diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Stem cells for medical use; pharmaceutical, medical, biomedical and veterinary preparations for the treatment of heart and kidney diseases

Medical, surgical, paramedical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for the treatment of genetic diseases and cancer of solid organs, including heart and muscle diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Medical instruments for the fusion of medicines, namely, syringes, infusion pumps, syringe systems comprising syringes and medical tubing for administering drugs, medical laboratory mixers, medical vial reconstitution mixers, nebulizers, medicine autoinjectors sold empty, and balloon catheters; Diagnostic apparatus for medical purposes, namely, for medical diagnostic testing related to heart and kidney diseases; infusion sets; medical and surgical implants made of artificial materials, namely, artificial heart and kidney synthetic tissue

Recorded and downloadable computer software and computer software platforms for data processing, storage, and analysis for the development of gene therapies; recorded and downloadable computer software and computer software platforms for data processing, storage, and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection, and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical 2D scanners, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; computers and data processing equipment intended for use in medical, biomedical, veterinary and pharmaceutical research and development

Active chemical ingredients used in the manufacture of medicines for treating heart and kidney diseases

Advertising services; Commercial business administration, business organization consulting, and business management; providing office functions; commercial business management; consulting services regarding company management; company communication services, namely, public relations and providing business information for potential investors; consulting services relating to personnel management; personnel management; providing commercial information in the field of life science, health technology and medical technology; providing marketing information; drawing up of statements of accounts; retail store and wholesale store services featuring chemical and medical products and preparations, medical instruments and apparatus, and software in the medical field

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 15, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 27, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 19, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 3, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 27, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 27, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 27, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 22, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 21, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 4, 2024 REPR